Törün Oya, Akçay Hüseyin, Şimşek Fatma Ela, Yenigün Ayşe
Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Izmir Katip Celebi University, Aydınlıkevler Cemil Meric Boulvard, 35640 Cigli, Izmir Turkey.
Private Practice, Izmir, Turkey.
J Maxillofac Oral Surg. 2025 Aug;24(4):1100-1107. doi: 10.1007/s12663-025-02435-1. Epub 2025 Jan 15.
Bone grafts are indispensable in augmentation procedures, and their properties influence the new bone formation. It has proved that the injectable platelet-rich fibrin has many positive effects on bone healing.
It was aimed to compare the effectiveness of the injectable platelet-rich fibrin (i-PRF) addition to bovine bone graft with different particle sizes on bone formation and vascularization in this study.
In 18 New Zealand rabbits, critical sized defects were created in the calvarium. Bovine bone grafts of two different particle sizes, small particles (SP) (0.25-1.0 mm) and large particles (LP) (1.0-2.0 mm) were applied with injectable platelet-rich fibrin (i-PRF) and without i-PRF. Animals were killed at 4 and 10 weeks for examining early and late bone healing histomorphometrically and immunohistochemically.
Group SP + i-PRF had the significantly greater amount of new bone formation in both healing periods. The immunoreactivity scores of the vascular endothelial growth factor (VEGF) and osteocalcin (OCN) were found to be significantly higher in Group SP + i-PRF than the other groups. There has been detected significant relationship between i-PRF addition and OCN staining scores.
In this study, which investigated the effectiveness of i-PRF in different particle sizes, it was concluded that i-PRF addition to small-particle bone graft increased new bone formation. There was no significant difference between two particle sizes of bone graft without i-PRF addition.
骨移植在骨增量手术中不可或缺,其特性会影响新骨形成。已证实可注射富血小板纤维蛋白对骨愈合有诸多积极作用。
本研究旨在比较添加可注射富血小板纤维蛋白(i-PRF)的不同粒径牛骨移植材料在骨形成和血管化方面的有效性。
对18只新西兰兔颅骨制造临界尺寸骨缺损。将两种不同粒径的牛骨移植材料,即小颗粒(SP)(0.25 - 1.0毫米)和大颗粒(LP)(1.0 - 2.0毫米),分别与可注射富血小板纤维蛋白(i-PRF)联合应用及不联合应用。在第4周和第10周处死动物,通过组织形态计量学和免疫组织化学方法检查早期和晚期骨愈合情况。
在两个愈合阶段,SP + i-PRF组的新骨形成量均显著更多。发现SP + i-PRF组的血管内皮生长因子(VEGF)和骨钙素(OCN)免疫反应性评分显著高于其他组。添加i-PRF与OCN染色评分之间存在显著相关性。
在本研究中,研究了不同粒径i-PRF的有效性,得出结论:向小颗粒骨移植材料中添加i-PRF可增加新骨形成。未添加i-PRF的两种粒径骨移植材料之间无显著差异。